Undervalued Stocks Based On Cash Flows

Results

147

18 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

147 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
HBAN
US$17.04-5.1%-1.4%US$34.4bUS$20.301.225.7%3.6%Banks
CVI
New
US$38.034.4%33.8%US$4.0bUS$31.4055.469.7%1.1%Energy
FORM
US$107.90-21.9%269.4%US$8.9bUS$138.6373.043.7%n/aSemiconductors
ALRS
US$32.86-1.9%47.8%US$816.1mUS$35.4029.740.6%2.7%Diversified Financials
SYM
US$41.83-1.2%-8.5%US$25.3bUS$64.32661.855.5%n/aCapital Goods
COHR
US$275.49-21.6%204.4%US$56.7bUS$416.0970.143.9%n/aTech
FLEX
US$106.65-18.0%101.3%US$40.8bUS$160.5040.544.9%n/aTech
MBLY
US$8.64-6.4%-37.4%US$7.7bUS$12.113.694.2%n/aAutomobiles
EBS
New
US$5.1815.1%-43.7%US$260.5mUS$11.000.397.5%n/aPharmaceuticals & Biotech
LKNC.Y
US$35.00-2.5%-5.9%US$11.6bUS$48.2120.123.2%n/aConsumer Services
BA
US$210.46-6.9%-7.2%US$169.3bUS$274.8579.642.9%0%Capital Goods
WLTH
US$9.220.7%n/aUS$1.4bUS$12.253.785.4%n/aDiversified Financials
ZETA
US$28.47-1.2%44.5%US$7.3bUS$31.364.549.1%n/aSoftware
NTRA
US$327.724.3%101.7%US$47.9bUS$336.7417.562.6%n/aPharmaceuticals & Biotech
SPT
US$10.348.3%-29.4%US$607.1mUS$10.441.3107.1%n/aSoftware
GSHD
New
US$73.0013.4%-15.7%US$2.6bUS$68.9249.220.4%0%Insurance
SWMR
US$39.78-15.5%n/aUS$492.9mUS$60.001549.7104.0%n/aCapital Goods
XERS
US$8.742.6%12.5%US$1.6bUS$11.714.855.9%n/aPharmaceuticals & Biotech
J
US$151.615.6%3.1%US$17.6bUS$162.5349.428.7%0.9%Commercial Services
GPC
US$135.692.4%-2.6%US$18.5bUS$140.38570.941.7%3.1%Retail
SE
US$115.68-3.2%-38.3%US$72.0bUS$155.2943.325.2%n/aRetail
MELI
US$1,947.909.0%-19.1%US$97.5bUS$2,256.5453.029.0%0%Retail
LOB
US$40.30-6.9%6.9%US$1.9bUS$46.251.526.8%0.3%Banks
BE
US$204.02-12.1%313.4%US$59.3bUS$275.08245.342.5%n/aCapital Goods
Page 1 of 5